{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:26:39Z","timestamp":1772843199441,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"Medical University of Silesia","doi-asserted-by":"publisher","award":["KNW-1-072\/N\/6\/0"],"award-info":[{"award-number":["KNW-1-072\/N\/6\/0"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2019.01.006","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T12:46:13Z","timestamp":1547642773000},"page":"1160-1167","source":"Crossref","is-referenced-by-count":13,"title":["Osteoprotegerin Assessment Improves Prediction of Mortality in Stroke Patients"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2697-7149","authenticated-orcid":false,"given":"Jaros\u0142aw","family":"Wajda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"\u015awiat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander J.","family":"Owczarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Holecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Du\u0142awa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniceta","family":"Brzozowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Olszanecka-Glinianowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Chudek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0001","first-page":"19","article-title":"Aktualne spojrzenie na rol\u0119 hiperhomocysteinemii w patogenezie mia\u017cd\u017cycy","volume":"1","author":"Naruszewicz","year":"2005","journal-title":"Pol Przegl Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3988\/jcn.2013.9.3.165","article-title":"Multimarkerapproach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis","volume":"9","author":"Musia\u0142ek","year":"2013","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0003","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","article-title":"Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Goldstein","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jvs.2007.09.058","article-title":"The relationship between serum levels of vascular calcification inhibitors and carotid plague vulnerability","volume":"47","author":"Kadoglou","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0005","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/01.STR.0000129790.00318.a3","article-title":"Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis","volume":"35","author":"Gollledge","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0006","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0100-879X2007000400001","article-title":"Bone metabolism and vascular calcification","volume":"40","author":"Danilevicius","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0007","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2010.03.013","article-title":"Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity","volume":"55","author":"Venuraju","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0008","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/CIRCRESAHA.108.189001","article-title":"RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway","volume":"104","author":"Panizo","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0009","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0010","first-page":"37","article-title":"Szlak RANKL\/RANK\/OPG w patogenezie chor\u00f3b nowe mo\u017cliwo\u015bci terapeutyczne","volume":"5","author":"Pytlik","year":"2009","journal-title":"Farm Przegl Nauk"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejcb.2008.06.004","article-title":"Pathophysiological roles of osteoprotegerin (OPG)","volume":"88","author":"Reid","year":"2009","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0012","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2362.2010.02308.x","article-title":"Coronary artery calcification and cardiovascular risk: the role of RANKL\/OPG signalling","volume":"40","author":"Quercioli","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0013","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s10354-010-0818-x","article-title":"Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help?","volume":"160","author":"Wagner","year":"2010","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0014","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2796.2009.02163.x","article-title":"Osteoprotegerin concentrations and prognosis in acute ischaemic stroke","volume":"267","author":"Jensen","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.09.033","article-title":"Osteoprotegerin, vascular calcification and atherosclerosis","volume":"204","author":"Van Campenhout","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejcb.2008.06.004","article-title":"Pathophysiological roles of osteoprotegerin (OPG)","volume":"88","author":"Reid","year":"2009","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0017","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00198-008-0648-5","article-title":"Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?","volume":"20","author":"Anagnostis","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0018","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/qjmed\/hci077","article-title":"Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies","volume":"98","author":"Hamerman","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0019","doi-asserted-by":"crossref","first-page":"75805","DOI":"10.1155\/2007\/75805","article-title":"The immune response is involved in atherosclerotic plaque calcification: could the RANKL\/RANK\/OPG system be a marker of plaque instability?","volume":"2007","author":"Montecucco","year":"2007","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/heartjnl-2012-302240","article-title":"Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP","volume":"99","author":"Mogelvang","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0021","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/147323001103900310","article-title":"The role of serum osteoprotegerin and S-100 protein levels in patients with acute ischaemic stroke: determination of stroke subtype, severity and mortality","volume":"39","author":"\u00dcst\u00fcnda\u011f","year":"2011","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0022","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3109\/1354750X.2012.727027","article-title":"Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients","volume":"17","author":"Song","year":"2012","journal-title":"Biomarkers"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0023","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.clinbiochem.2013.05.048","article-title":"Plasma Osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis","volume":"46","author":"Kim","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCHEARTFAILURE.110.957332","article-title":"Osteoprotegerin predicts progression of chronic heart failure: results from CORONA","volume":"4","author":"Ueland","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0025","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0026","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.atherosclerosis.2005.01.042","article-title":"Osteoprotegerin plasma concentration correlate with severity of periferal artery disease","volume":"182","author":"Ziegler","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0027","first-page":"7","article-title":"Osteoprotegerin\u2014does it play a protective role in the pathogenesis of bone loss In obese perimenopausal women?","volume":"58","author":"Holecki","year":"2007","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0028","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1017\/S1368980017003901","article-title":"Socio-economic determinants of vitamin D deficiency in the older Polish population: results from the PolSenior study","volume":"21","author":"Wyskida","year":"2018","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/environ-2015-0038","article-title":"Weather types in Sosnowiec (Poland) during the period 1999-2013","volume":"2","author":"Dobrowolska","year":"2014","journal-title":"Environ Socioecon Stud"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0030","doi-asserted-by":"crossref","unstructured":"Holecki M, Chudek J, Owczarek A, et al. Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly Clin Endocrinol. 2015;82:900-909. doi: 10.1111\/cen.12759.","DOI":"10.1111\/cen.12759"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mce.2014.10.007","article-title":"Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli","volume":"399","author":"Ito","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0032","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejvs.2006.10.018","article-title":"Texture analysis of ultrasonic images of symptomatic carotid plaques can identify those plaques associated with ipsilateral embolic brain infarction","volume":"33","author":"Kakkos","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0033","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1161\/01.STR.0000190895.51934.43","article-title":"The vulnerable carotid artery plaque: current imaging methods and new perspectives","volume":"36","author":"Nighoghossian","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0034","doi-asserted-by":"crossref","first-page":"e3381","DOI":"10.1097\/MD.0000000000003381","article-title":"Serum osteoprotegerin is associated with calcified carotid plaque: a strobe-compliant observational study","volume":"95","author":"Choi","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0035","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1161\/01.STR.0000080534.98416.A0","article-title":"Cause-specific mortality after first cerebral infarction. A population-based study","volume":"34","author":"Vernino","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0036","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12883-015-0317-1","article-title":"Three-year survival and recurrence after first-ever stroke: the Joinville stroke registry","volume":"15","author":"Cabral","year":"2015","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0037","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.STR.0000165926.74213.e3","article-title":"Reccurent stroke risk is higher than cardiac event risk after initial stroke\/transient ischemic attac","volume":"36","author":"Brown","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0038","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/ajkd.2002.31402","article-title":"Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure","volume":"39","author":"Kazama","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0039","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1515\/CCLM.2009.075","article-title":"Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease","volume":"47","author":"Mesquita","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.01.006_bib0040","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1440-1797.2011.01481.x","article-title":"Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder","volume":"16","author":"Jiang","year":"2011","journal-title":"Nephrology"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305719300060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305719300060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T17:21:49Z","timestamp":1606065709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305719300060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1052305719300060"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2019.01.006","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}